The expression of Fgl2 on CD8+ TIL in melanoma patients treated with immune checkpoint therapy was interrogated using the single cell RNA sequencing dataset published by Sade-Feldman et al. 27 (Fig. 1j). The gene discussed is FGL2; the disease is melanoma.